Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo) If you have or had Hodgkin lymphoma…
adminSeptember 19, 2017
Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris) If you have or had Hodgkin lymphoma…
adminJuly 26, 2017
Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin…
adminJuly 26, 2017
Lymphoma Canada Awareness Day at Queen's Park Cocktail reception 5:00 p.m. – 7:00 p.m. Guests must…
adminJuly 19, 2017
Treatment with a new targeted therapy, duvelisib, has shown sustained efficacy and safety in a…
adminJuly 7, 2017
Treatment with a new targeted therapy, duvelisib, has shown sustained efficacy and safety in a…
adminJuly 7, 2017
Recently, a group of Manitoba CLL experts formed the Integrated Multidisciplinary CLL Research Cluster –…
adminJuly 7, 2017
If you have or had Hodgkin lymphoma or you are or were a caregiver of…
adminJune 5, 2017
Living Well with CLL in Montreal Chronic Lymphocytic Leukemia Connection Group Seeking to meet the…
adminJune 5, 2017
